Direxion Daily S&P Biotech Bear 3X ETF
LABD
17 hedge funds and large institutions have $17.3M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 3 closing their positions.
198% more call options, than puts
Call options by funds: $24.6M | Put options by funds: $8.27M
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
13.37% more ownership
Funds ownership: 28.21% → 41.58% (+13%)
2% more capital invested
Capital invested by funds: $16.9M → $17.3M (+$388K)
0% more funds holding
Funds holding: 17 → 17 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.1M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$700K |
| 3 |
Goldman Sachs
New York
|
+$693K |
| 4 |
VF
Virtu Financial
New York
|
+$392K |
| 5 |
Jane Street
New York
|
+$366K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$3.19M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.33M |
| 3 |
HF
HRT Financial
New York
|
-$1M |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
-$786K |
| 5 |
Squarepoint
New York
|
-$363K |
LABD Hedge Fund Activity: Q4 2021 in Review
17 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q4 2021, worth a combined $17.3M — up 2.3% from $16.9M a quarter earlier.
Fund positioning in LABD was balanced in Q4 2021: 3 funds opened new positions, 3 closed out, 8 added to existing stakes and 4 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $1.1M. The largest seller was Boxer Capital, exiting entirely with an estimated $3.19M sold.
- 17 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $17.3M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q4 2021, up 2.3% quarter-over-quarter.
- 3 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q4 2021 and 3 closed out, a net change of 0 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q4 2021 was Susquehanna International Group, an estimated $1.1M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q4 2021 was Boxer Capital, an estimated $3.19M sold.
Based on aggregated 13F filings for Q4 2021.